Abstract: The present disclosure relates to antibodies that bind human LAIR1 ("anti human LAIR1 antibodies" or "anti human LAIR1 antibodies") compositions comprising such anti human LAIR1 antibodies and methods of using such anti human LAIR1 antibodies.
| # | Name | Date |
|---|---|---|
| 1 | 202517035992-STATEMENT OF UNDERTAKING (FORM 3) [14-04-2025(online)].pdf | 2025-04-14 |
| 3 | 202517035992-Sequence Listing in PDF [14-04-2025(online)].pdf | 2025-04-14 |
| 4 | 202517035992-REQUEST FOR EXAMINATION (FORM-18) [14-04-2025(online)].pdf | 2025-04-14 |
| 5 | 202517035992-PROOF OF RIGHT [14-04-2025(online)].pdf | 2025-04-14 |
| 6 | 202517035992-POWER OF AUTHORITY [14-04-2025(online)].pdf | 2025-04-14 |
| 7 | 202517035992-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [14-04-2025(online)].pdf | 2025-04-14 |
| 8 | 202517035992-FORM 18 [14-04-2025(online)].pdf | 2025-04-14 |
| 9 | 202517035992-FORM 1 [14-04-2025(online)].pdf | 2025-04-14 |
| 10 | 202517035992-DRAWINGS [14-04-2025(online)].pdf | 2025-04-14 |
| 11 | 202517035992-DECLARATION OF INVENTORSHIP (FORM 5) [14-04-2025(online)].pdf | 2025-04-14 |
| 12 | 202517035992-COMPLETE SPECIFICATION [14-04-2025(online)].pdf | 2025-04-14 |
| 13 | 202517035992-RELEVANT DOCUMENTS [16-04-2025(online)].pdf | 2025-04-16 |
| 14 | 202517035992-MARKED COPIES OF AMENDEMENTS [16-04-2025(online)].pdf | 2025-04-16 |
| 15 | 202517035992-FORM-26 [16-04-2025(online)].pdf | 2025-04-16 |
| 16 | 202517035992-FORM 13 [16-04-2025(online)].pdf | 2025-04-16 |
| 17 | 202517035992-AMMENDED DOCUMENTS [16-04-2025(online)].pdf | 2025-04-16 |
| 18 | 202517035992-FORM-26 [01-05-2025(online)].pdf | 2025-05-01 |
| 19 | 202517035992-FORM 3 [15-07-2025(online)].pdf | 2025-07-15 |